Operating Lease, Right-of-Use Asset of Passage BIO, Inc. from 31 Mar 2022 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Passage BIO, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2022 to 31 Dec 2025.
Passage BIO, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $10,168,000, a 26% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Passage BIO, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$10,168,000	-$3,635,000	-26%	31 Dec 2025	10-K	03 Mar 2026	2025	FY
Q3 2025	$13,001,000	-$1,036,000	-7.4%	30 Sep 2025	10-Q	10 Nov 2025	2025	Q3
Q2 2025	$13,273,000	-$3,549,000	-21%	30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q1 2025	$13,540,000	-$3,547,000	-21%	31 Mar 2025	10-Q	13 May 2025	2025	Q1
Q4 2024	$13,803,000	-$3,055,000	-18%	31 Dec 2024	10-K	03 Mar 2026	2025	FY
Q3 2024	$14,037,000	-$3,008,000	-18%	30 Sep 2024	10-Q	13 Nov 2024	2024	Q3
Q2 2024	$16,822,000	-$2,591,000	-13%	30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$17,087,000	-$2,503,000	-13%	31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q4 2023	$16,858,000	-$2,865,000	-15%	31 Dec 2023	10-K	04 Mar 2025	2024	FY
Q3 2023	$17,045,000	-$2,845,000	-14%	30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q2 2023	$19,413,000	-$640,000	-3.2%	30 Jun 2023	10-Q	07 Aug 2023	2023	Q2
Q1 2023	$19,590,000	-$622,000	-3.1%	31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$19,723,000			31 Dec 2022	10-K	04 Mar 2024	2023	FY
Q3 2022	$19,890,000			30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$20,053,000			30 Jun 2022	10-Q	04 Aug 2022	2022	Q2
Q1 2022	$20,212,000			31 Mar 2022	10-Q	16 May 2022	2022	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.